Studies in animal models found that co-expression of heterozygous mutant GCase and mutant SNCA exacerbated the observed symptoms compared to the expression of alpha-synuclein alone [41], further providing evidence that mutant GCase increases the risk for PD. Here, SNCA is linked to Parkinson disease.